Tobam West Pharmaceutical Services Inc Transaction History

Tobam

$234 Million
Q1 2025

A detailed history of Tobam transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Tobam holds 14,155 shares of WST stock, worth $3.09 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

14,155

Previous 4,513 213.65%

Holding current value

$3.09 Million

Previous $1.48 Million 114.41%

% of portfolio

1.35%

Previous 0.45%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$199.11 - $347.87 $1.92 Million - $3.35 Million	9,642 Added 213.65%	14,155 $3.17 Million
Q4 2024 Jan 28, 2025	BUY	$285.69 - $344.0 $232,265 - $279,672	813 Added 21.97%	4,513 $1.48 Million
Q3 2024 Oct 09, 2024	BUY	$277.16 - $333.3 $671,558 - $807,585	2,423 Added 189.74%	3,700 $1.11 Million
Q2 2024 Jul 29, 2024	SELL	$314.68 - $395.94 $2.97 Million - $3.73 Million	-9,429 Reduced 88.07%	1,277 $421,000
Q1 2024 May 02, 2024	BUY	$338.27 - $413.0 $3.48 Million - $4.25 Million	10,295 Added 2504.87%	10,706 $4.24 Million
Q4 2023 Jan 26, 2024	SELL	$318.29 - $392.21 $52,836 - $65,106	-166 Reduced 28.77%	411 $145,000
Q3 2023 Oct 31, 2023	BUY	$354.9 - $412.41 $30,521 - $35,467	86 Added 17.52%	577 $216,000
Q1 2023 May 03, 2023	BUY	$232.5 - $346.47 $22,552 - $33,607	97 Added 24.62%	491 $170,000
Q2 2022 Aug 02, 2022	SELL	$280.61 - $420.45 $24,413 - $36,579	-87 Reduced 18.09%	394 $119,000
Q1 2022 Apr 25, 2022	BUY	$357.49 - $445.92 $82,222 - $102,561	230 Added 91.63%	481 $198,000
Q3 2020 Nov 12, 2020	BUY	$224.99 - $288.02 $56,472 - $72,293	251 New	251 $69,000

Others Institutions Holding WST

# of Institutions

803

Shares Held

66.2M

Call Options Held

415K

Put Options Held

275K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $16.1B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account